Drug of the calcium-blocker class useful in the treatment of hypertension, angina, and heart failure. Diltiazem is sold under the trade name Cardizem. Adverse effects include cardiac arrhythmias, hypotension, and liver damage.
A calcium channel blocker administered orally or intravenously to manage hypertension, angina pectoris, Prinzmetal’s angina, supraventricular tachyarrhythmias, and rapid ventricular rates in atrial flutter or fibrillation. Its therapeutic classes are antianginal, antiarrhythmic, and antihypertensive.
Diltiazem is a medication classified as a calcium channel blocker, prescribed for the treatment of hypertension (high blood pressure) and angina pectoris (chest pain caused by inadequate blood supply to the heart muscle). Possible side effects of diltiazem may include headaches, loss of appetite, nausea, constipation, and swelling in the ankles.